Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097180614> ?p ?o ?g. }
- W2097180614 endingPage "254" @default.
- W2097180614 startingPage "247" @default.
- W2097180614 abstract "A unique mRNA produced in leukemic cells from a t(15;17) acute promyelocytic leukemia (APL) patient encodes a fusion protein between the retinoic acid receptor α (RARα) and a myeloid gene product called PML. Studies have reported that neutrophil elastase (NE) cleaves bcr-1-derived PML-RARα in early myeloid cells, leaving only the nuclear localization signal (NLS) of PML attached to RARα. The resultant NLS-RARα fusion protein mainly localizes to, and functions within, the cell nucleus. It is speculated that NLS-RARα may act in different ways from the wild-type RARα, but its biological characteristics have not been reported. This study takes two approaches. Firstly, the NLS-RARα was silenced with pNLS-RARα-shRNA. The mRNA and protein expression of NLS-RARα were detected by RT-PCR and Western blot respectively. Cell proliferation in vitro was assessed by MTT assay. Flow cytometry (FCM) was used to detect the differentiation of cells. Secondly, the NLS-RARα was over-expressed by preparation of recombinant adenovirus HL-60/pAd-NLS-RARα. The assays of mRNA and protein expression of NLS-RARα, and cell proliferation, were as above. By contrast, cell differentiation was stimulated by all trans retinoic acid (ATRA) (2.5µmol/L) at 24h after virus infection of pAd-NLS-RARα, and then detected by CD11b labeling two days later. The transcription and translation of C-MYC was detected in HL-60/pAd-NLS-RARα cells which treated by ATRA. Our results showed that compared to the control groups, the expression of NLS-RARα was significantly reduced in the HL-60/pNLS-RARα-shRNA cells, and increased dramatically in the HL-60/pAd-NLS-RARα cells. The proliferation was remarkably inhibited in the HL-60/pNLS-RARα-shRNA cells in a time-dependent manner, but markedly promoted in the HL-60/pAd-NLS-RARα cells. FCM outcome revealed the differentiation increased in HL-60/pNLS-RARα-shRNA cells, and decreased in the HL-60/pAd-NLS-RARα cells treated with 2.5µmol/L ATRA. The expression of C-MYC increased strikingly in HL-60/pAd-NLS-RARα cells treated with 2.5µmol/L ATRA. Down-regulation of NLS-RARα expression inhibited the proliferation and induced the differentiation of HL-60 cells. On the contrary, over-expression of NLS-RARα promoted proliferation and reduced the ATRA-induced differentiation of HL-60 cells." @default.
- W2097180614 created "2016-06-24" @default.
- W2097180614 creator A5036623415 @default.
- W2097180614 creator A5042016187 @default.
- W2097180614 creator A5070538645 @default.
- W2097180614 creator A5071145913 @default.
- W2097180614 creator A5073701887 @default.
- W2097180614 date "2014-01-01" @default.
- W2097180614 modified "2023-10-16" @default.
- W2097180614 title "NLS-RARα Promotes Proliferation and Inhibits Differentiation in HL-60 Cells" @default.
- W2097180614 cites W100165276 @default.
- W2097180614 cites W146982080 @default.
- W2097180614 cites W1553544241 @default.
- W2097180614 cites W1579062391 @default.
- W2097180614 cites W1919133853 @default.
- W2097180614 cites W1965388358 @default.
- W2097180614 cites W1966494491 @default.
- W2097180614 cites W1967415817 @default.
- W2097180614 cites W1969652209 @default.
- W2097180614 cites W1971273692 @default.
- W2097180614 cites W1983057459 @default.
- W2097180614 cites W1985714890 @default.
- W2097180614 cites W1995254238 @default.
- W2097180614 cites W1995451068 @default.
- W2097180614 cites W2012253608 @default.
- W2097180614 cites W2012661561 @default.
- W2097180614 cites W2018788643 @default.
- W2097180614 cites W2029215616 @default.
- W2097180614 cites W2034618235 @default.
- W2097180614 cites W2053131171 @default.
- W2097180614 cites W2062700640 @default.
- W2097180614 cites W2064772366 @default.
- W2097180614 cites W2085124463 @default.
- W2097180614 cites W2086666061 @default.
- W2097180614 cites W2099431941 @default.
- W2097180614 cites W2112738731 @default.
- W2097180614 cites W2118261046 @default.
- W2097180614 cites W2134435180 @default.
- W2097180614 cites W2319691036 @default.
- W2097180614 cites W2951244282 @default.
- W2097180614 doi "https://doi.org/10.7150/ijms.6518" @default.
- W2097180614 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3917113" @default.
- W2097180614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24516348" @default.
- W2097180614 hasPublicationYear "2014" @default.
- W2097180614 type Work @default.
- W2097180614 sameAs 2097180614 @default.
- W2097180614 citedByCount "13" @default.
- W2097180614 countsByYear W20971806142014 @default.
- W2097180614 countsByYear W20971806142016 @default.
- W2097180614 countsByYear W20971806142017 @default.
- W2097180614 countsByYear W20971806142018 @default.
- W2097180614 countsByYear W20971806142020 @default.
- W2097180614 countsByYear W20971806142021 @default.
- W2097180614 countsByYear W20971806142022 @default.
- W2097180614 crossrefType "journal-article" @default.
- W2097180614 hasAuthorship W2097180614A5036623415 @default.
- W2097180614 hasAuthorship W2097180614A5042016187 @default.
- W2097180614 hasAuthorship W2097180614A5070538645 @default.
- W2097180614 hasAuthorship W2097180614A5071145913 @default.
- W2097180614 hasAuthorship W2097180614A5073701887 @default.
- W2097180614 hasBestOaLocation W20971806141 @default.
- W2097180614 hasConcept C104317684 @default.
- W2097180614 hasConcept C123894998 @default.
- W2097180614 hasConcept C153911025 @default.
- W2097180614 hasConcept C185592680 @default.
- W2097180614 hasConcept C186435350 @default.
- W2097180614 hasConcept C2776601000 @default.
- W2097180614 hasConcept C2780723820 @default.
- W2097180614 hasConcept C2781121885 @default.
- W2097180614 hasConcept C40767141 @default.
- W2097180614 hasConcept C49805395 @default.
- W2097180614 hasConcept C502942594 @default.
- W2097180614 hasConcept C55493867 @default.
- W2097180614 hasConcept C62112901 @default.
- W2097180614 hasConcept C86803240 @default.
- W2097180614 hasConcept C95444343 @default.
- W2097180614 hasConceptScore W2097180614C104317684 @default.
- W2097180614 hasConceptScore W2097180614C123894998 @default.
- W2097180614 hasConceptScore W2097180614C153911025 @default.
- W2097180614 hasConceptScore W2097180614C185592680 @default.
- W2097180614 hasConceptScore W2097180614C186435350 @default.
- W2097180614 hasConceptScore W2097180614C2776601000 @default.
- W2097180614 hasConceptScore W2097180614C2780723820 @default.
- W2097180614 hasConceptScore W2097180614C2781121885 @default.
- W2097180614 hasConceptScore W2097180614C40767141 @default.
- W2097180614 hasConceptScore W2097180614C49805395 @default.
- W2097180614 hasConceptScore W2097180614C502942594 @default.
- W2097180614 hasConceptScore W2097180614C55493867 @default.
- W2097180614 hasConceptScore W2097180614C62112901 @default.
- W2097180614 hasConceptScore W2097180614C86803240 @default.
- W2097180614 hasConceptScore W2097180614C95444343 @default.
- W2097180614 hasIssue "3" @default.
- W2097180614 hasLocation W20971806141 @default.
- W2097180614 hasLocation W20971806142 @default.
- W2097180614 hasLocation W20971806143 @default.
- W2097180614 hasLocation W20971806144 @default.
- W2097180614 hasOpenAccess W2097180614 @default.
- W2097180614 hasPrimaryLocation W20971806141 @default.